Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: Searching for the best risk marker by multivariate modeling

Journal of the American Society of Nephrology

Volumn 16, Issue 3 SUPPL. 1, 2005, Pages

  Tripepi, Giovanni ^a   Mallamaci, Francesca ^a   Zoccali, Carmine ^a,b  

^a CNR   (Italy)

^b BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CELL ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; AUTACOID; CYTOKINE;

ADULT; AGED; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HUMAN; INFLAMMATION; KIDNEY FAILURE; MALE; MORTALITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; COMPARATIVE STUDY; DISEASE COURSE; FOLLOW UP; HOSPITALIZATION; KIDNEY FUNCTION TEST; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; RENAL REPLACEMENT THERAPY; SENSITIVITY AND SPECIFICITY; SURVIVAL;

ADULT; AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CELL ADHESION MOLECULES; COHORT STUDIES; CYTOKINES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION MEDIATORS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 20844445415     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2004110972     Document Type: Conference Paper

References (30)

1. Zoccali C, Mallamaci F, Tripepi G: Inflammation and atherosclerosis in end stage renal disease. Blood Purif 21: 29-36, 2003
2. Stenvinkel P, Alvestrand A: Inflammation in end-stage renal disease: Sources, consequences, and therapy. Semin Dial 15: 329-337, 2002
3. Mackiewicz A, Speroff T, Ganapathi MK, Kushner I: Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines. J Immunol 146: 3032-3037, 1991
4. Fantuzzi G, Zheng H, Faggioni R, Benigni F, Ghezzi P, Sipe JD, Shaw AR, Dinarello CA: Effect of endotoxin in IL-1β deficient mice. J Immunol 157: 291-296, 1996
5. Marino MW, Dunn A, Graid D, Inglese M, Noguchi Y, Richards E, Jungbluth A, Wada H, Moore M, Williamsson B, Basu S, Old LJ: Characterization of tumor necrosis factor-α deficient mice. Proc Natl Acad Sci U S A 94: 8093-8098, 1997
6. Stenvinkel P, Barany P, Heimburger O, Pecoits-Filho R, Lindholm B: Mortality, malnutrition and atherosclerosis in ESRD: What is the role of interleukin-6? Kidney Int 80: 103-108, 2002
7. Whitman SC, Ravisankar P, Daugherty A: Interleukin-18 enhances atherosclerosis in apolipoprotein E(-/-) mice through release of interferon-gamma. Circ Res 90: E34-E38, 2002
8. Blankenberg S, Luc G, Ducimetiere P, Arveiler D, Ferrieres J, Amouyel P, Evans A, Cambien F, Tiret L; PRIME Study Group: Interleukin-18 and the risk of coronary heart disease in European men: The Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 108: 2453-2459, 2003
9. Blankenberg S, Tiret L, Bickel C, Peetz D, Cambian F, Meyer J, Rupprecht HJ: Interleukin-18 as a strong predictor of cardiovascular death in stable and unstable angina. Circulation 106: 24-30, 2002
10. Zoccali C, Bebedetto FA, Mallamaci F, Tripepi G, Fermo I, Foca A, Paroni R, Malatino LS: Inflammation is associated with carotid atherosclerosis in dialysis patients. J Hypertens 18: 1207-1213, 2000
11. Stenvinkel P, Heimburger O, Jogestrand T: Elevated interleukin-6 predicts progressive carotid artery atherosclerosis on dialysis patients: Association with Chlamydia pneumoniae seropositivity. Am J Kidney Dis 39: 274-282, 2002
12. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55: 648-658, 1999
13. Yeun JY, Levine RA, Mantadilok V, Kaysan GA: C-reactive protein predicts all cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 35: 469-476, 2000
14. Qureshi AR, Alvestrand A, Divino-Filho JC, Gutierrez A, Heimburger O, Lindholm B, Bergstrom J: Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 13[Suppl 1]: S28-S36, 2002
15. Kimmel PL, Phillips TM, Simmens SJ, Peterson RA, Weihs KL, Alleyne S, Cruz I, Yanovski JA, Veis JH: Immunological function and survival in hemodialysis patients. Kidney Int 54: 236-244, 1998
16. Papagianni A, Kalovoulos M, Kirmizis D, Vainas A, Belechri AM, Alexopoulos E, Memmos D: Carotid atherosclerosis in associated with inflammation and endothelial cell adhesion molecules in chronic hemodialysis patients. Nephrol Dial Transplant 18: 113-119, 2003
17. Stenvinkel P, Wanner C, Metzger T, Heimburger O, Mallamaci F, Tripepi G, Malatino LS, Zoccali C: Inflammation and outcome in end stage renal failure: Does female gender constitute a survival advantage? Kidney Int 62: 1791-1798, 2002
18. Akohoshi T, Kobayashi N, Hosaka S, Sekiyama N, Wada C, Kondo H: In vivo induction of monocyte chemotactic and activating factor in patients with chronic renal failure. Nephrol Dial Transplant 10: 2244-2249, 1995
19. Rabb H, Calderon E, Bittle PA, Ramirez G: Alterations in soluble intracellular adhesion molecules-1 and vascular cell adhesion molecules-1 in hemodialysis patients. Am J Kidney Dis 27: 239-243, 1996
20. Stenvinkel P, Lindholm B, Heimburger M, Heimburger O: Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: Association with malnutrition, inflammation, and cardiovascular disease. Nephrol Dial Transplant 15: 1624-1630, 2000
21. Zoccali C, Bode-Boger S, Mallamaci F, Benedetto F, Tripepi G, Malatino L, Cataliotti A, Bellanuova I, Fermo I, Frolich J, Boger R: Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study. Lancet 358: 2113-2117, 2001
22. Mallamaci F, Zoccali C, Tripepi G, Fermo I, Benedetto FA, Cataliotti A, Bellanuova I, Malatino LS, Soldarini A: Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. Kidney Int 61: 609-614, 2002
23. Collet D: Modelling Survival Data in Medical Research, London, Chapmann & Hall, 1994, pp 72-85
24. Vasan RS, Sullivan LM, Roubenoff R, Dinarello CA, Harris T, Benjamin EJ, Sawyer DB, Levy D, Wilson PW, D'Agostino RB; Framingham Heart Study: Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: The Framingham Heart Study. Circulation 107:1486-1491, 2003
25. Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K, Rubin SM, Ding J, Simonsick EM, Harris TB, Pahor M: Inflammatory markers and onset of cardiovascular events: Results from the Health ABC study. Circulation 108: 2317-2322, 2003
26. Koukkunen H, Penttila K, Kemppainen A, Halinen M, Penttila I, Rantanen T, Pyorala K: C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-alpha in the prognostic classification of unstable angina pectoris. Ann Med 33: 37-47, 2001
27. Kimmel PL, Chawla LS, Amarasinghe A, Peterson RA, Weihs KL, Simmens SJ, Alleyne S, Burke HB, Cruz I, Veis JH: Anthropometric measures, cytokines and survival in haemodialysis patients. Nephrol Dial Transplant 18: 326-332, 2003
28. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V: Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link? Atherosclerosis 148: 209-214, 2000
29. Pecoits-Filho R, Barany P, Lindholm B, Heimburger O, Stenvinkel P: Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant 17: 1684-1688, 2002
30. Pober JS, Cotran RS: Cytokines and endothelial cell biology. Physiol Rev 70: 427-451, 1990